000 01818 a2200481 4500
005 20250514184701.0
264 0 _c20040916
008 200409s 0 0 eng d
022 _a0969-8051
024 7 _a10.1016/j.nucmedbio.2003.11.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHenriksen, Gjermund
245 0 0 _aSterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
_h[electronic resource]
260 _bNuclear medicine and biology
_cMay 2004
300 _a441-9 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActinium
_xadministration & dosage
650 0 4 _aAlpha Particles
_xtherapeutic use
650 0 4 _aCarrier Proteins
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCoated Materials, Biocompatible
_xchemical synthesis
650 0 4 _aDrug Carriers
_xchemical synthesis
650 0 4 _aDrug Stability
650 0 4 _aFemale
650 0 4 _aFolate Receptors, GPI-Anchored
650 0 4 _aFolic Acid
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Fab Fragments
_ximmunology
650 0 4 _aLiposomes
_xchemical synthesis
650 0 4 _aMetabolic Clearance Rate
650 0 4 _aOvarian Neoplasms
_xmetabolism
650 0 4 _aRadioimmunotherapy
_xmethods
650 0 4 _aRadiopharmaceuticals
_xadministration & dosage
650 0 4 _aRadium
_xadministration & dosage
650 0 4 _aReceptors, Cell Surface
_xmetabolism
650 0 4 _aStereoisomerism
700 1 _aSchoultz, B W
700 1 _aMichaelsen, T E
700 1 _aBruland, Ø S
700 1 _aLarsen, R H
773 0 _tNuclear medicine and biology
_gvol. 31
_gno. 4
_gp. 441-9
856 4 0 _uhttps://doi.org/10.1016/j.nucmedbio.2003.11.004
_zAvailable from publisher's website
999 _c14806605
_d14806605